| Search Immortality Topics: | |
Home » Anatomy » Osteal Therapeutics, Inc. Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7 for Periprosthetic Joint Infection
Osteal Therapeutics, Inc. Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7 for Periprosthetic Joint Infection
Posted: November 5, 2022 at 1:42 am
Six-month outcomes are expected in second quarter of 2023 Six-month outcomes are expected in second quarter of 2023
Read the original here:
Osteal Therapeutics, Inc. Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7 for Periprosthetic Joint Infection
Recommendation and review posted by G. Smith
